Body Composition and Blood-Based Prognostic Markers in Immunotherapy-Treated Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT07192926 · COMPLETED
Trial details
- NCT number
- NCT07192926
- Sponsor
- Ankara Etlik City Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-01
- Primary completion
- 2025-03-30
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.